Document is current
Any future updates will be listed below
-
Authors
Nia, Hadi T. https://orcid.org/0000-0003-1970-9901
Munn, Lance L.
Jain, Rakesh K. https://orcid.org/0000-0001-7571-3548
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (DP2HL168562, F32-CA216944, R21EB031332, R01-HL128168, R01-CA204949, R01-CA259253, R01-CA208205, R01-NS118929, U01-CA261842, U01-CA 224348, R35-CA197743)
Arnold and Mabel Beckman Foundation (Beckman Young Investigator Award)
NSF | ENG/OAD | Division of Civil, Mechanical and Manufacturing Innovation (CAREER)
Boston University (Kilachand Fund Award)
U.S. Department of Defense (HT9425241053)
- License Information
-
More Information
Article History
Received: 8 February 2024
Accepted: 11 November 2024
First Online: 15 January 2025
Competing interests
: R.K.J. received consultant and/or SAB fees from Cur, DynamiCure, Elpis, Merck and SynDevRx; owns equity in Accurius, Enlight and SynDevRx; and served on the boards of trustees of Tekla Healthcare Investors, Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund. The Massachusetts General Hospital has applied for patents related to concepts discussed in this Review. L.L.M. receives equity from Bayer and is a consultant for SimBioSys. The remaining author declares no competing interests.
